TCL Archive Von Eschenbach takes leave of absence from NCI, resigns from C-Change board. Acting FDA commissioner’s drug approval strategy rooted in unproven science. Von Eschenbach told NCI deputies he might drop in on meetings. Who’s really in charge? October 7, 2005
TCL Archive In Brief: EORTC-NCI Exchange Program Invites U.S. applicants; USC Seeks Eye Melanoma Patients December 5, 1986
TCL Archive Facilities Survey Finrs $25 Million a Year for Five Years Needed From NCI By Year 1990 March 8, 1985
